Direkt zum Inhalt
Merck

α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.

Journal of medicinal chemistry (2012-06-27)
Karin Brücher, Boris Illarionov, Jana Held, Serena Tschan, Andrea Kunfermann, Miriam K Pein, Adelbert Bacher, Tobias Gräwert, Louis Maes, Benjamin Mordmüller, Markus Fischer, Thomas Kurz
ZUSAMMENFASSUNG

Specific inhibition of enzymes of the non-mevalonate pathway is a promising strategy for the development of novel antiplasmodial drugs. α-Aryl-substituted β-oxa isosteres of fosmidomycin with a reverse orientation of the hydroxamic acid group were synthesized and evaluated for their inhibitory activity against recombinant 1-deoxy-d-xylulose 5-phosphate reductoisomerase (IspC) of Plasmodium falciparum and for their in vitro antiplasmodial activity against chloroquine-sensitive and resistant strains of P. falciparum . The most active derivative inhibits IspC protein of P. falciparum (PfIspC) with an IC(50) value of 12 nM and shows potent in vitro antiplasmodial activity. In addition, lipophilic ester prodrugs demonstrated improved P. falciparum growth inhibition in vitro.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Fosmidomycin Natriumsalz Hydrat, ≥95% (NMR)